AU752378B2 - Supporting material for medicinal purposes - Google Patents

Supporting material for medicinal purposes Download PDF

Info

Publication number
AU752378B2
AU752378B2 AU25217/99A AU2521799A AU752378B2 AU 752378 B2 AU752378 B2 AU 752378B2 AU 25217/99 A AU25217/99 A AU 25217/99A AU 2521799 A AU2521799 A AU 2521799A AU 752378 B2 AU752378 B2 AU 752378B2
Authority
AU
Australia
Prior art keywords
backing material
adhesive composition
medical purposes
purposes according
backing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU25217/99A
Other versions
AU2521799A (en
Inventor
Peter Himmelsbach
Marike Sinnen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beiersdorf AG
Original Assignee
Beiersdorf AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beiersdorf AG filed Critical Beiersdorf AG
Publication of AU2521799A publication Critical patent/AU2521799A/en
Application granted granted Critical
Publication of AU752378B2 publication Critical patent/AU752378B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive plasters or dressings
    • A61F13/0203Adhesive plasters or dressings having a fluid handling member
    • A61F13/0223Adhesive plasters or dressings having a fluid handling member characterized by parametric properties of the fluid handling layer, e.g. absorbency, wicking capacity, liquid distribution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive plasters or dressings
    • A61F13/0203Adhesive plasters or dressings having a fluid handling member
    • A61F13/0226Adhesive plasters or dressings having a fluid handling member characterised by the support layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive plasters or dressings
    • A61F13/0246Adhesive plasters or dressings characterised by the skin adhering layer
    • A61F13/025Adhesive plasters or dressings characterised by the skin adhering layer having a special distribution arrangement of the adhesive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/02Adhesive plasters or dressings
    • A61F13/0246Adhesive plasters or dressings characterised by the skin adhering layer
    • A61F13/0256Adhesive plasters or dressings characterised by the skin adhering layer characterized by the parametric properties of the adhesive
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/44Medicaments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/58Adhesives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices

Abstract

The invention relates to supporting material for medicinal purposes. The supporting material is characterized in that it is a non-woven material which is topstitched with sewing threads and which has a maximum tensile strength of at least 10 N/cm. In addition, the supporting material is partially or completely coated on at least one side with a doped adhesive material.

Description

WO 99/39756 PCT/EP99/00738 Description Backing material for medical purposes The invention relates to a backing material for medical purposes, preferably a medical plaster, which is coated on at least one side completely or partially with a doped adhesive composition.
As backing materials for medical purposes, numerous materials based on films, wovens, knits, nonwovens, gels or foams have already been disclosed and are also employed in practice. The materials, which are often coated with a self-adhesive composition as well, are required to be skin-compatible, generally permeable to air and water vapour, and also easy to model and conformable. Based on these requirements, a very thin or soft backing is frequently preferred. For handling and in use, however, the backing materials are also required to be of sufficient strength and possibly of limited extensibility. Furthermore, the backing material should retain sufficient strength and low extensibility even after becoming wet through.
Thin backings, especially those made of nonwovens, are highly permeable to air and water vapour. For certain applications, however, their strength is too low and their elongation too high. Moreover, the cushioning effect is inadequate for these favourable backings.
Specific applications, an example being rheumatism plasters, require inelastic backings having high strength in the direction of stress. This is achieved by using woven or knitted fabric backings, usually of cotton or viscose. Backing raterials of this kind, with appropriately high basis weight, are generally cost- 2 intensive. High conformability and modelability can only be achieved by means of woven fabric of relatively low strength. When such fabrics are stressed, however, they generally exhibit too low a degree of cushioning, which is undesirable for the application.
When the dressings listed become wet through, they generally lose strength or become more extensible. This is likewise undesirable for their use and has to date been compensated by more frequent changing of dressings, which, however, is cost-intensive.
Thus, AU 73555/74 describes by way of example a glass filament-reinforced backing material for medical application based on foam.
US 4,668,563 describes a glass fibre-reinforced material which, however, is elastic. All backing materials mentioned, however, are not reinforced by stitching.
DE 44 42 092 and DE U 94 01 037 describe adhesive tapes based on stitchbonded webs which are partially coated on the reverse side of the backing. Such adhesive tapes are used preferably in cable bandaging.
DE 44 42 093 is also based on the use of a nonwoven as backing for an adhesive tape; in this case, a crosslaid fibre web is described which is reinforced by the formation of loops from the fibres of the web.
DE 44 42 507 likewise discloses an adhesive tape for cable bandaging, but bases it on so-called Kunit or Multikunit webs.
A utility or special suitability of these backing materials for medical purposes, however, cannot be inferred from the documents--cited. In particular, the publications give indications neither of sufficient 3 skin compatibility of the adhesive compositions nor of functionally secured bonding on the skin or an advantageous permeability to air and water vapour.
Furthermore, doping with active substances is not mentioned.
US 4,773,238 describes a fibre web with lengthwise overstitching, the stitching seams being intended to amount to no more than 20% by weight based on the weight of the total nonwoven. Proposed in accordance with the invention is the utility as an insert for filters in dust filtration.
US 4,967,740 gives a general disclosure of backing materials for use in medical supply, which are produced in a one-step process. In this process, the backing is impregnated simultaneously with an elastomer and with a release solution. In this way, the material can be presented without release paper on a roll. Doping with active substances is not mentioned.
In a listing of a large number of appropriate backings, mention is made, inter alia, of overstitched nonwovens, without the skilled worker being given any indication as to how the nonwoven should, specifically, be configured in order to meet the requirements placed on a medical backing.
Transdermal therapeutic systems (TTS) are forms of administration of medicaments which deliver one or more medicaments to the skin over a defined period at their site of use. A distinction is made between systemic and local administration forms.
With systemic administration forms, the active substance passes through the skin into the blood circulation by diffusion and is able to act within the 4 body as a whole.
Local administration forms, on the other hand, act only at the applied sites. The active substance remains in the skin or in the underlying layers.
Strongly adhering plasters are usually coated over the whole of their area with a rubber adhesive composition.
These adhesive compositions then permit secure bonding, for example at critical points such as joints, over the duration of several days. The adhesive bonding of such products to the skin, however, shows distinct skin irritations following removal, and mechanical stressing of the skin. Without auxiliary means, the bond cannot be released painlessly.
Further adhesive compositions are based on acrylate systems or on block copolymers.
The abovementioned adhesive compositions may be pressure-sensitive self-adhesive compositions, in which case the compositions may be present for processing in a carrier matrix. The carrier matrix is understood to comprise common organic or inorganic solvents or dispersants.
Systems without a carrier matrix are referred to as 100% systems and are likewise not unknown. They are processed in the elastic or thermoplastic state. A common mode of processing is that of the melt.
Pressure-sensitive hot-melt adhesive compositions of this kind have also already been described in the prior art. They are based on natural or synthetic rubbers and/or other synthetic polymers.
An advantage of the 100% sys-t-ems is that they avoid the operation of removing the carrier matrix, i.e. the 5 auxiliary means, thereby raising the productivity of processing and at the same time reducing the expenditure on machinery and the energy costs. In addition, this reduces the occurrence of residues of the carrier matrix. This, in turn, is to the benefit of a reduction in the allergenic potential.
Because of their high level of hardness, adhesion to the skin is a problem for such 100% systems.
It is also known to apply such self-adhesive compositions not only over the entire area but also in the form of a pattern of dots, for example by screen printing (DE-C 42 37 252), in which case the dots of adhesive may also differ in their size and/or distribution (EP-B 353 972), or by gravure printing of lines which interconnect in the longitudinal and transverse directions (DE-C 43 08 649).
The advantage of the patterned application is that the adhesive materials, given an appropriate porous backing material, are permeable to air and water vapour and, in general, are readily redetachable.
A disadvantage of these products, however, is that if the area covered by the adhesive layer, which per se is impermeable, is too large there is a corresponding reduction in the permeability to air and water vapour, and the consumption of adhesive composition rises; and also, if the area covered by the adhesive layer is small, the adhesion properties deteriorate, i.e. the product is detached too readily from the substrate, especially in the case of heavy, textile backing materials.
O) Numerous embodiments of active substance plasters have 6 already been described in the prior art, some of which operate in accordance with the reservoir principle, where the active substance is delivered, for example, via a membrane, in some cases also with a matrix system or with a relatively complex multilayer structure.
It is also known that the adhesive composition of the plaster may be employed as the active substance matrix.
In addition to self-adhesive compositions applied from solution, hot-melt adhesive compositions have also been proposed for this purpose, as for example in EP-A 663 431, EP-A 452 034, EP-A 305 757, DE-A 43 10 012, DE-A 42 22 334 and DE-C 42 24 325. The active substances listed in these documents, if named at all, have been systemic ones. Use of the backing of the invention is not described.
As examples of active substance plasters, mention may be made of the active substance plasters which aid the circulation, belonging to the group of the locally active therapeutic systems. The use of such plasters is indicated for the treatment of rheumatic complaints, sciatica, lumbago, stiff neck, shoulder/arm pain and also muscular strains and sprains, muscular aching or muscle, joint and nerve pain in the region of the locomotor system.
Capsaicin, belladonna and nonivamide are known active substances in such locally acting, circulation-aiding plasters. Because of their use on the locomotor system they are generally required to adhere strongly.
Usually, the plasters are coated over their whole area with a resin-rubber adhesive composition which comprises the active substance.
However, plasters of this kind, which usually have to 7 be applied over a relatively large area, may in some cases lead to mechanical skin irritations following removal in the case of sensitive patients.
The disadvantage depicted also applies to active substance plasters comprising substances other than those mentioned.
For instance, WO 94/02123 describes an active substance plaster based on pressure-sensitive hot-melt adhesive compositions and comprising low-melting and/or readily volatile active substances in a concentration of from to 25% by weight. Use of the backing of the invention is not described.
EP 0 663 431 A2, EP 0 443 759 A3, EP 0 452 034 A2 and US 5,371,128 describe uses of pressure-sensitive, silicone-based hot-melt adhesives with various additives and in differentiated structural forms. Use of the backing of the invention is not described.
DE 43 10 012 Al describes the structure of a dermal therapeutic system comprising meltable poly(meth)acrylate mixtures.
In particular, the release of a plurality of active substances from polymer systems which [lacuna] only one polymer type appears difficult. Systems comprising two or more polymer types are, however, critical in their compatibility. Use of the backing of the invention is not described.
DE 43 16 751 Cl describes a multi-chamber system for administering active substances.
EP 0 439 180 describes an active substance plaster for administering tulobuterol. EP 0 305 757 describes an active substance plaster for administering nicotine.
EP 0 305 758 describes an active substance plaster for administering nitroglycerine.
EP 0 305 756 describes an adhesive composition of substances and its preparation and use. Use of the backing of the invention is not described.
DE 37 43 945 describes an adhesive composition for delivering substances, and the production process. In the case of the pressure-sensitive hot-melt adhesive composition described, which is based on SIS, the device is not self-adhesive. The processing ranges indicated therein lie well below those of hot-melt adhesive compositions and for such described systems would not provide sufficient anchoring of the adhesive composition. Use of the backing of the invention is not described.
WO 96/22083 indicates a polyisobutylene adhesive for transdermal purposes, •which has a tackifier with a high glass transition point. Use of the backing of the invention is not described.
"•JP 07-196505 describes the administration of inkomethacin [sic] in hot-melt o pressure-sensitive adhesives. In this case, a polyethylene foam is used as backing material. Use of the backing of the invention is not described.
S•It is an object of the present invention to overcome or ameliorate at least one of the disadvantages of the prior art, or to provide a useful alternative.
Any discussion of the prior art throughout the specification should in no way be considered as an admission that such prior art is widely known or forms part of o common general knowledge in the field.
Summary of the Invention The present invention relates to a nonwoven-based backing material which has been coated with a doped adhesive composition and is suitable for medical requirements and which, moreover, does not have the disadvantages known from Sthe prior art.
According to a first aspect, the present invention provides backing material for medical purposes, wherein the backing material is a nonwoven overstitched by means of yams and having an ultimate tensile stress strength of at least 10 N/cm and the backing material is coated partially or over its full area on at least one side with an adhesive composition comprising an active substance as herein described.
According to a second aspect, the present invention provides backing material for medical purposes, wherein the backing material is a nonwoven which is reinforced by the formation of stitches formed by loops from the fibres of the web, the ultimate tensile stress strength of the backing material being at least 10 N/cm, and the backing material is coated partially or over its full area on at least one side with a self-adhesive composition comprising an active substance as herein described.
According to a third aspect, the present invention provides a product comprising the backing material according to the first or second aspect.
Unless the context clearly requires otherwise, throughout the description and the 15 claims, the words 'comprise', 'comprising', and the like are to be construed in an inclusive sense as opposed to an exclusive or exhaustive sense; that is to say, in the sense of "including, but not limited to".
A nonwoven overstitched by means of yams is used as backing material for medical purposes, the number of stitches on the nonwoven being advantageously at least oe 20 3/cm, preferably from 5/cm to 50/cm. The ultimate tensile stress strength of the backing material is at least 10 N/cm, preferably from 20 to 450 N/cm, with particular eooo preference from 30 to 250 N/cm, and the backing material is coated partially or over its full area on at least one side with a doped adhesive composition.
The yams preferably have a water absorption of less than 30%, with particular preference less than 20%. The water absorption can be regenerated by the atmospheric humidity.
Accordingly, materials which can be used for the yarns are, advantageously, polymeric fibres made from polypropylene, polyester, polyamide, aramid or polyethylene, and also mineral fibres such as glass fibres or carbon fibres. In addition it is also possible to use multistrand yams or mixed multistrands, 9a especially Sirospun yams. For specific applications, single- or multi-strand fibre blend yams may also be employed. Furthermore, the yams can have been at least partly coloured in order to make the backing material more visually appealing.
For specific applications, the yam can also be elastic. From this there is then regenerated an elastic base support having an elongation of up to 250% at a o on** *o/ g 10 load of 10 N/cm. Mention may be made here, for example, as a polyamide yarn (Lycra DuPont) [sic] A backing material of this kind generates a compression force of from 0.2 N/cm to 10 N/cm at an elongation of from 20% to 70% and is used in compression technology.
In the case of the alternative embodiment of the subject-matter of the invention, a nonwoven is used as backing material for medical purposes. In this case, the nonwoven is reinforced by the formation of stitches formed by loops from the fibres of the web, the number of stitches on the web being advantageously at least 3/cm, preferably from 5/cm to 50/cm. The ultimate tensile stress strength of the backing material is at least 10 N/cm, preferably from 20 to 450 N/cm, with particular preference from 50 to 250 N/cm, and the backing material is coated partially or over its full area on at least one side with a doped adhesive composition.
The backing materials are based on known nonwovens which are mechanically consolidated either by overstitching with separate yarns or by looping.
In the first case, the resulting structures are the web-yarn stitchbonds. For their production, a fibre web is taken, which can, for example, be in cross-plating configuration, and is overstitched with separate yarns in pillarstitch formation or tricot formation.
These nonwovens are known by the name "Maliwatt" (from the company Malimo) or Arachne.
With the second type of consolidation, again, preferably a cross-plated web is taken. In the course of the consolidation operation, needles draw out fibres from the web itself and form them into loops, with stitches being formed in p-iTlarstitch formation. This Sweb stitchbond is in circulation under the name 11 "Malivlies" [Mali Fleece], again from the company Malimo.
An overview of the various kinds of mechanically consolidated fibre nonwovens can be found in the article "Kaschierung von Autopolsterstoffen mit Faservliesen" [Laminating car upholstery materials with fibre webs] by G. Schmidt, Melliand Textilberichte 6/1992, pages 479 to 486.
Advantageously, the webs have longitudinal stitches, in which case the orientation of the yarns ought to be aligned in accordance with the stresses on the backing material in use.
Starting materials which can be used for the nonwoven material are generally all organic and inorganic, natural- and synthetic-based fibre materials. Examples that may be mentioned include viscose, cotton, silk, polypropylene, polyester, polyurethane, polyamide, aramid or polyethylene, and also mineral fibres such as glass fibres or carbon fibres. The present invention is, however, not restricted to the said materials; rather, it is possible to use a large number of other fibres for web formation.
The fibres used to form the web preferably have a water retention capacity of more than preferably between 2 to [sic] 70%, with particular preference between 3 and In one preferred embodiment, the backing material has an ultimate tensile stress elongation of less than preferably less than 15%, with particular preference less than For a web overstitched with yarns, this is achieved firstly by the use of a ya-r-n- material having a higher modulus of elasticity and secondly with the use of 12 stitching which ensures a yarn position which is stretched as much as possible.
Advantageous combinations of material are, for example, yarns of high-strength polymer fibres such as polyamide, polyester, highly stretched polyethylene, or mineral fibres such as glass, and initial web materials such as cotton or staple viscose rayon.
For a web in which the formation of stitches takes place by the loops being formed from the fibres of the web, the material of the initial web should be selected accordingly; corresponding comments apply to the stitching.
It has also been found advantageous for the backing material to have a basis weight of up to 500 g/m 2 preferably from 10 to 350 g/m 2 In one further advantageous embodiment, the backing material can be torn by hand perpendicular to the orientation of the stitches and/or in the direction of the stitches. This finds its application when the backing material of the invention is wound up on itself to form a roll.
In another embodiment, this tearability is unnecessary.
In this case, the materials involved may be prepunched plaster materials.
Furthermore, the backing material may have been reinforced with one or more monofil, multifil, staple fibre or spun fibre yarns and/or with oriented highstrength fibres, the yarns and/or fibres having in particular a strength of at---least 40 cN/tex.
N In addition it is also possible to employ multi-strand 13 yarns or mixed multistrands, especially Sirospun yarns.
For specific applications, single- or multi-strand fibre blend yarns may also be employed. These may comprise, for example, core-spun yarns or special staple fibre core-spun yarns.
An advantage here is that by combining different fibre types it is possible to achieve particular properties or specific properties in the reinforcement thread.
Examples of this are the combinations of polyester or polyamide with cotton or staple viscose rayon.
The reinforcement fibres or filaments here can consist of organic or inorganic materials: for example, and preferably, glass, carbon, polyester or specific polyamides, and the reinforcement fibres may also have been at least partly coloured in order to render the backing material more visually appealing. In this way it is readily possible to differentiate visually the reinforced backing. Coloured glass or polymer filaments are particularly suitable for this purpose.
In one advantageous embodiment the backing material attains through the addition of high-strength fibres or filaments an ultimate tensile stress strength of more than 40 cN/tex, an ultimate tensile stress strength of more than 50 N/cm and an ultimate tensile stress elongation of less than 25% with a basis weight of less than 140 g/m 2 The number of attached or introduced filaments or highstrength fibres depends primarily on the particular intended use and on the desired ultimate tensile stress strength and ultimate tensile stress elongation of the backing material, on its inherent nature and on the respective strength of th4e fibres and filaments themselves, and can therefore be varied within 14 relatively wide limits.
Advantageous combinations of material are, for example, reinforcement filaments or fibres of high-strength polymer fibres such as polyamide, polyester, highly stretched polyethylene, or mineral fibres such as glass, and initial web materials such as cotton or staple viscose rayon.
In addition, the reinforcements are preferably inserted specifically in accordance with the direction of stress of the backing material, i.e. in the longitudinal direction. If more appropriate, however, they can also extend only or additionally in the transverse or oblique direction or, for example, in curved, spiral or zigzag formation, or randomly.
In one further advantageous embodiment, the backing material can be torn by hand perpendicular to the orientation of the reinforcement and/or in the direction of the reinforcement.
With greater strength of the nonwoven material and an increasing proportion of reinforcement fibres, the backing withstands greater stress and loading. Even very highly reinforced backing materials are able to absorb or allow the passage of large amounts of moisture, and hence provide a pleasant sensation for the user, with the reinforcements absorbing little or no moisture and so undergoing no change in their properties.
The adhesive composition may preferably include different active substances, the quantitative concentrations of the active--substance or substances in N the adhesive composition further preferably being
-K-
15 between 0.01 to about 60% by weight, preferably from 0.1 to 20% by weight.
Under the designation "active substances" in connection with the pres.ent invention there are understood chemical elements, organic and inorganic compounds which are able to migrate from the constituents of a generic adhesive composition that comprise them and so bring about a desired effect. Among the fields of application of the adhesive composition of the invention, human and veterinary medicine is of particular importance, a configuration of the invention in plaster form being particularly preferred here.
Typical substances which may be administered in this case by way of devices produced in accordance with the invention are the following: aceclidine, amfetaminil, amfetamine, amyl nitrite, apophedrine, atabrine, alpostadil, azulene, arecoline, anethole, amylene hydrate, acetylcholine, acridine, adenosine triphosphoric acid, L-malic acid, alimemazine, allithiamine, allyl isothiocyanate, aminoethanol, apyzine, apiole, azatadine, alprenolol, ethinazone, benzoyl peroxide, benzyl alcohol, bisabolol, bisnorephedrine, butacetoluide, benactyzine, camphor, colecalciferol, chloral hydrate, clemastine, chlorobutanol, capsaicin, cyclopentamine, clobutinol, chamazulene, dimethocaine, codeine, chloropromazine, quinine, chlorothymol, cyclophosphamide, cinchocaine, chlorambuzil, chlorphenesin, diethylethane, divinylethane, dexchlorpheniramine, dinoprostone, dixyrazine, ephedrine, ethosuximide, enallylpropymal, emylcamate, erythrol tetranitrate, emetine, enflurane, eucalyptol, etofenamate, ethylmorphine, fentanyl, fluanisone, guaiazulene, halothane, hyoscyamine, histamine, fencarbamide, hydroxycaine, hexylresorcinol, isoaminile 16 citrate, isosorbide dinitrate, ibuprofen, iodine, iodoform, isoaminile, lidocaine, lopirine, levamisole, methadone, methyprylon, methylphenidate, mephenesin, methylephedrine, meclastine, methopromazine, mesuximide, nikethamide, norpseudoephedrine, menthol, methoxyfluran, methylpentinol, metixene, mesoprostol, oxytetracaine, oxyprenolol, oxyphenbutazone, oxyquinoline, pinene, prolintane, procyclidine, piperazine, pivazide, phensuximide, procaine, phenindamine, promethazine, pentetrazol, profenamine, perazine, phenol, pethidine, pilocarpine, prenylamine, phenoxybenzamine, resochin, scopolamine, salicylic acid ester, sparteine, trichloroethylene, timolol, trifluoperazine, tetracaine, trimipramine, tranylcypromine, trimethadione, tybamate, thymol, thioridazine, valproic acid and verapamil, and also other active substances familiar to the skilled worker that can be absorbed through the skin, including mucosae. This list is of course not exhaustive.
The active substances are dispersed in the adhesive composition preferably in commercial homogenizers, such as for example mixers, kneading apparatus, roll mills or screw systems. The active substance can be added to the ready-prepared adhesive composition. The active substance can also, for example, be incorporated into an intermediate stage or into the initial mixture.
As adhesive compositions it is possible with advantage to use self-adhesive compositions based on natural and synthetic rubbers and on other synthetic polymers such as acrylates, methacrylates, polyurethanes, polyolefins, polyvinyl derivatives, polyesters or silicones with corresponding additives such as tackifier resins, plasticiz-ers, stabilizers and other uxiliaries where necessary.
T i 17 The adhesive composition may additionally comprise polymers which form a physically or chemically crosslinked gel.
Thermoplastic hot-melt adhesive compositions, in particular, have advantageous properties and are favoured for reasons concerned with the production process.
Their softening point should be higher than 500C, since the application temperature in the case of the coating is generally at least 900C, preferably between 1200C and 150'C, or between 1800C and 2200C in the case of special adhesive compositions such as silicones.
If desired, postcrosslinking by means of high-energy radiation such as UV rays or electron beams may be applied.
Preferred hot-melted adhesive compositions based on block copolymers are notable for their diverse possibilities for variation, since the controlled reduction in the glass transition temperature of the self-adhesive composition as a result of the selection of the tackifiers, plasticizers, polymer molecule size and molecular distribution of the starting components ensures the required bonding to the skin in a manner appropriate to their function, even at critical points of the human locomotor system.
The high shear strength of the hot-melt adhesive composition is achieved through the high cohesiveness of the polymer. The good tack results from the range of tackifiers and plasticizers employed.
For especially strongly adhesive systems, the hot-melt 18 adhesive composition is preferably based on block copolymers, especially A-B-A block copolymers or mixtures thereof. The hard phase A is principally polystyrene or its derivatives and the soft phase B contains ethylene, propylene, butylene, butadiene, isoprene or mixtures thereof, particular preference being given here to ethylene and butylene or mixtures thereof.
Polystyrene blocks, however, may also be present in the soft phase B in amounts of up to 20%. The overall proportion of styrene should, however, always be less than 35% by weight. Preferably, styrene proportions of between 5% and 30% are preferred, since a relatively low proportion of styrene makes the adhesive composition more conformable.
The controlled blending of diblock and triblock copolymers is particularly advantageous, preference being given to a proportion of diblock copolymers of less than 80% by weight.
In one advantageous embodiment the hot-melt adhesive composition has the following stated composition: from 10% by weight to 90% by weight of block copolymers, from 5% by weight to 80% by weight of tackifiers such as oils, waxes, resins and/or mixtures thereof, preferably mixtures of resins and oils, less than 60% by weight of plasticizers, less than 15% by weight of additives, less than 5% by weight of stabilizers, and less than 60% by weight of active substance.
The aliphatic or aromatic c-ils, waxes and resins used as tackifiers are preferably hydrocarbon oils, waxes 19 and resins, the consistency of the oils, such as paraffinic hydrocarbon oils, or of the waxes, such as paraffinic hydrocarbon waxes, accounting for their favourable effect on bonding to the skin. Plasticizers used are medium-chain or long-chain fatty acids and/or their esters. These additions serve to establish the adhesion properties and the stability. If desired, further stabilizers and other auxiliaries are employed.
Filling the adhesive composition with mineral or organic fillers, fibres or hollow or solid microbeads is possible.
The self-adhesive composition has a softening point of more than 700C, preferably from 800C to 1400C.
The hot-melt self-adhesive compositions are preferably formulated so that at a frequency of 0.1 rad/s they have a dynamic-complex glass transition temperature of less than 150C, preferably from 30C to -30oC, with very particular preference from -3°C to -250C.
Stringent requirements are placed in terms of the adhesion properties on medical backing materials. For ideal use the hot-melt adhesive composition should possess a high tack. There should be functionally appropriate bond strength to the skin and to the reverse of the backing. So that there is no slipping, the hot-melt adhesive composition is also required to have a high shear strength.
By the controlled reduction in the glass transition temperature of the adhesive composition, which is a result of the selection of the tackifiers, the plasticizers, the polymer molecule size and the molecular distribution of the starting components, the N_ required, functionally appropriate bonding to the skin 20 and to the reverse of the backing is achieved.
The high shear strength of the adhesive composition which is employed here is obtained by virtue of the high cohesiveness of the block copolymer. The good tack is the result of the range of tackifiers and plasticizers employed.
Product properties such as tack, glass transition temperature and shear stability can be quantified readily using a dynamo-mechanical frequency measurement. In this case, use is made of a rheometer controlled by shearing stress.
The results of this measurement method give information of the physical properties of a substance by taking into account the viscoelastic component. In this instance, at a predetermined temperature, the selfadhesive composition is set in oscillation between two plane-parallel plates at variable frequencies and with low deformation (linear viscoelastic region). Via a pickup control unit, with computer assistance, the quotient (Q tan 6) between the loss modulus viscous component) and the storage modulus elastic component) is determined.
Q tan 6 A high frequency is chosen for the subjective sensing of the tack, and a low frequency for the shear strength.
The glass transition temperature is the temperature at which amorphous or partially crystalline polymers undergo transition from the liquid or rubber-elastic state to the hard-elastic or glassy state, or vice versa (R6mpp Chemie-Lexikon, 9th Ed., Volume 2, page 21 1587, Georg Thieme Verlag Stuttgart New York, 1990) It corresponds to the maximum of the temperature function at a predetermined frequency.
For medical applications in particular, a relatively low glass transition point is required.
Designation T9 Conformability Tack low low frequency/ RT high frequency/ frequency RT Hot-melt adhesive -10 2 0 C tan 6 0.35 0.05 tan 6 1.70 0.10 composition A Hot-melt adhesive -9 2 0 C tan 6 0.22 0.03 tan 6 1.00 0.03 composition B Preference is given in accordance with the invention to self-adhesive compositions for which the ratio of the viscous component to the elastic component at a frequency of 100 rad/s and at 25 0 C is greater than 0.7, or to self-adhesive compositions for which the ratio of the viscous component to the elastic component at a frequency of 0.1 rad/s at 25 0 C is less than 0.4, preferably from 0.35 to 0.02 and, with very particular preference, between 0.3 and 0.1.
It is also advantageous, especially with use for medical products, if the adhesive composition is applied partially to the backing material, for example by means of halftone printing, screen printing, thermoflex printing or intaglio printing, because backing materials which have been adhesively treated in a continuous applied line may, under unfavourable circumstances, on application, induce mechanical irritations of the skin and are generally impermeable to air and water vapour.
Preference is given to application in the form of (0 polygeometric domes and, especially, domes where the 22 ratio of diameter to height is less than 5:1. Printed application of other forms and patterns on the backing material is also possible for example, a printed image in the form of alphanumeric character combinations or patterns such as matrices, stripes and zigzag lines.
The adhesive composition can be distributed uniformly over the backing material; alternatively, it can be applied with a thickness or density which varies over the area, as is appropriate for the function of the product.
The principle of thermal screen printing consists in the use of a rotating, heated, seamless, drum-shaped, perforated, cylindrical screen which is fed via a nozzle with the preferred hot-melt self-adhesive composition. A specially shaped nozzle lip (circular or square bar) presses the hot-melt adhesive composition, which is fed in via a channel, through the perforation of the screen wall and onto the backing web that is conveyed past it. This web is guided by means of a counterpressure roller against the external jacket of the heated screen drum at a rate which corresponds to the peripheral speed of the rotating screen drum.
In this context, the formation of the small domes of adhesive takes place by the following mechanism: The pressure of the nozzle bar conveys the hot-melt adhesive composition through the screen perforation onto the backing material. The size of the domes formed is determined by the diameter of the screen perforation. The screen is lifted from the backing in accordance with the rate of transportation of the backing web (rotary speed of the screen drum) As a consequence of the high adhesion of the adhesive 23 composition and the internal cohesion of the hot-melt, the limited supply of hot-melt adhesive composition in the perforations is drawn in sharp definition from the base of the dome that is already adhering to the backing and is conveyed by the pressure of the bar onto the backing.
After the end of this transportation, the more or less strongly curved surface of the dome forms over the predefined base area in dependence on the rheology of the hot-melt adhesive composition. The height-to-base ratio of the dome depends on the ratio of the performation diameter to the wall thickness of the screen drum and on the physical properties (flow behaviour, surface tension and contact angle on the backing material) of the self-adhesive composition.
For the screen in thermal screen printing, the web-tohole ratio can be less than 3:1, preferably less than or equal to 1:1, and in particular equal to 1:3.
The above-described mechanism of formation of the domes preferentially requires backing materials that are absorbent or at least wettable by hot-melt adhesive compositions. Non-wetting backing surfaces must be pretreated by chemical or physical techniques. This can be effected by additional measures such as corona discharge, for example, or by coating with substances which improve wetting.
Using the printing technique indicated it is possible to lay down the size and shape of the domes in a defined manner. The bond strength values which are relevant for use and which determine the quality of the products formed are within very narrow tolerances in the case of proper coating-;--The base diameter of the domes can be chosen from 10 to 5000 pm, the height of 24 the domes from 20 to about 2000 pm, preferably from to 1000 pm, the low-diameter range being intended for smooth backings and the range of greater diameter and greater dome height being intended for rough or highly porous backing materials.
The positioning of the domes on the backing is laid down in a defined manner by the geometry of the applicator unit, for example the gravure or screen geometry, which can be varied within wide limits. With the aid of the parameters indicated it is possible, by way of adjustable variables, to establish with very great precision the desired profile of properties of the coating, harmonized with various backing materials and applications.
The backing material is preferably coated at a rate of more than 2 m/min, preferably from 20 to 200 m/min, the chosen coating temperature being greater than the softening temperature.
The self-adhesive composition can be applied to the backing material at a weight per unit area of greater than 15 g/m 2 preferably between 90 g/m 2 and 500 g/m 2 with very particular preference between 130 g/m 2 and 500 g/m 2 The percentage of the area that is coated with the self-adhesive composition should be at least 20% and can range up to approximately 95%, for specific products preferably from 40% to 60% and from 70% to This can be achieved, if appropriate, by multiple application, in which case it is also possible, if desired, to use self-adhesive compositions having different properties.
The combination of the preferred hot-melt adhesive 25 composition and the preferred partial coating on the one hand ensures reliable bonding of the medical product to the skin and, on the other hand, allergic or mechanical skin irritations, at least which are visually perceptible, are ruled out, even in the case of use extending over a number of days.
The epilation of corresponding body regions and the transfer of composition to the skin are negligible owing to the high cohesiveness of the adhesive, since the adhesive does not attach to the skin and hair; rather, the anchorage of the adhesive composition to the backing material, at up to 12 N/cm (sample width), is good for medical applications.
Because of the intended breakage points that have been formed in the coating, layers of skin are no longer displaced with one another or against one another in the course of detachment. The non-displacement of these layers of skin and the relatively low level of epilation lead to an unprecedented degree of painlessness in such strongly adhering systems. In addition, the individual biomechanical control of bond strength, which exhibits a demonstrable reduction in the bond strength of these plasters, assists detachability. The applied backing material shows good proprioreceptive effects.
Depending on the backing material and its temperature sensitivity, the hot-melt adhesive composition can be applied directly or can be applied first to an auxiliary support and then to the ultimate backing. In addition, subsequent calendering of the coated product and/or pretreatment of the backing, such as corona irradiation, may be advantageous for better anchorage of the adhesive film. 26 In addition, treatment of the hot-melt adhesive composition with an electron beam postcrosslinking, or a UV irradiation, may result in an improvement in the desired properties.
In a further advantageous embodiment, the self-adhesive compositions are foamed before being applied to the backing material.
In this case the self-adhesive compositions are preferably foamed using inert gases such as nitrogen, carbon dioxide, noble gases, hydrocarbons or air, or mixtures thereof. In many cases, foaming additionally by thermal decomposition of gas-evolving substances, such as azo, carbonate and hydrazide compounds, has been found to be suitable.
The degree of foaming, i.e. the gas content, should be at least about 5% by volume and can range up to about 85% by volume. In practice, levels of from 10% by volume to 75% by volume, preferably 50% by volume, have been found to be appropriate. Operating at relatively high temperatures of approximately 1000C and with a comparatively high internal pressure produces very open-pored adhesive foam layers which are particularly permeable to air and water vapour.
The advantageous properties of the foamed self-adhesive coatings, such as low consumption of adhesive, high tack and good conformity, even on uneven surfaces, owing to the elasticity and plasticity, and also the initial tack, can be utilized to best effect, very particularly, in the field of medical products.
The use of breathable coatings in conjunction with elastic and likewise breathable backing materials produces a level of wear comfort which is perceived 27 subjectively by the user as being more pleasant.
A particularly suitable method of preparing the foamed self-adhesive composition operates by the foam mixing system. In this system, the thermoplastic self-adhesive composition is reactive with the intended gases such as, for example, nitrogen, air or carbon dioxide in various volume proportions (from about 10% by volume to by volume) in a stator/rotor system under high pressure and at a temperature above the softening point (approximately 1200C).
Whereas the gas entry pressure is greater than 100 bar, the mixing pressures between gas and thermoplastic in the system are from 40 to 100 bar, preferably from to 70 bar. The pressure-sensitive adhesive foam produced in this way can subsequently be passed through a line into the applicator unit. In the applicator unit, commercially customary nozzles, extruder systems or chamber systems are used.
By virtue of the foaming of the self-adhesive composition and the open pores in the composition which form as a result, and given the use of an inherently porous backing, the products coated with the adhesive composition have good permeability to water vapour and air. The amount of adhesive compositions required is considerably reduced without adverse effect on the adhesion properties. The adhesive compositions have a surprisingly good tack, since per gramme of composition there is more volume and thus more adhesion surface for wetting of the substrate that is to be bonded, and the plasticity of the adhesive compositions is increased by virtue of the foam structure. Anchoring to the backing material is also improved by this means. Moreover, the foamed adhesive coating, a-s- already mentioned, gives d the products a soft and conforming feel.
ODc onA 28 Foaming also generally reduces the viscosity of the adhesive compositions. This lowers the melt energy, and even thermally unstable backing materials can be coated directly.
The backing material coated with the adhesive composition can have an air permeability of greater than 1 cm 3 (cm 2 preferably greater than 15 cm 3 /(cm 2 with very particular preference greater than 70 cm 3 /(cm 2 and also a water vapour permeability of greater than 500 g/(m 2 *24h), preferably greater than 1000 g/(m 2 *24h), with very particular preference greater than 2000 g/(m 2 *24h) Furthermore, the backing material can also be provided with other finishes or treatments. These include, for example, corona, flame or plasma pretreatments, in order to increase the anchoring of the self-adhesive composition to the base web. In addition, the calendering of the backing material or of the web as yet untreated with pressure-sensitive self-adhesive composition, for the purpose of further consolidation and/or improvement in the anchoring of the pressuresensitive self-adhesive composition, is an advantageous treatment.
In addition, on the side opposite to that coated with self-adhesive composition, the backing material can be finished with a water-repellent layer or impregnation which prevents rapid soaking on contact with water or perspiration. In addition to the known impregnations, this can also be done by the sewing-on of a sheet, advantageously a water vapour permeable sheet, by means of yarns directly during the--consolidation of the web.
The backing material can, furthermore, be finished with 29 a release layer or impregnation and/or coating which reduces the bond strength of the self-adhesive composition. In this case as well, in addition to the known release materials, it is also possible to sew on a sheet, advantageously a water vapour permeable sheet, directly during the consolidation of the web.
Another procedure which has been found to be advantageous is the lamination of the web backing with at least one additional layer of foams or sheets, since by this means a combination of properties of particular type is obtained. A foam has a substantially higher damping quality than an unlaminated backing. Sheets can be used, for example, for sealing the surface.
Furthermore, the backing material can be coated with metallic substances by vapour deposition.
Finally, following the coating operation, the backing material can be lined with a backing material which repels adhesive, such as siliconized paper, or can be provided with a wound pad or with padding.
It is particularly advantageous for the backing material to be sterilizable, preferably by means of y (gamma) radiation. Particularly suitable for subsequent sterilization, therefore, are hot-melt adhesive compositions based on block copolymers which contain no double bonds. This applies in particular to styrene-butylene-ethylene-styrene block copolymers or styrene-butylene-styrene block copolymers. This procedure is not accompanied by any applicationsignificant changes in the adhesive properties.
The backing material of -the invention has a bond strength on the reverse side of the backing of at least 30 N/cm, in particular a bond strength of between N/cm and 5 N/cm. Greater bond strengths may be achieved on other substrates.
Advantageously it has been found that a reinforced backing material with such an adhesive coating, on becoming wet through as is unavoidable, for example, in the course of water sports activities has a stability which is better than that of customary commercial backing material. The relative increase in the ultimate tensile stress elongation of selfadhesively treated backing materials according to the invention after becoming wet through is only half as great as in the case of customary commercial selfadhesively treated backing materials.
By virtue of this the backing materials of the invention, which indeed are thus essentially inelastic, become useful for specific medical purposes, and it is also possible to employ backing materials whose use hitherto was impossible owing to lack of strength and/or excessive elongation.
With preference it is possible to use backing materials based on wovens, knits, nonwovens or composite products, provided they otherwise meet the requirements of medical use.
Example 1 The text below describes by way of example a preferred backing material, without thereby wishing to restrict the invention unnecessarily.
The backing material used was-a viscose-based nonwoven.
S The nonwoven was overstitched with a polyester yarn, 31 the yarn count being 22/cm sample width. The water absorption of the polyester yarn was The backing material was calendered and impregnated.
The backing material thus produced had an ultimate tensile stress strength of 50 N/cm and an ultimate tensile stress elongation of 28% in the lengthwise direction. The basis weight was 120 g/cm 2 Wetting the backing material completely was not possible owing to the choice of reinforcement materials. Without a load, the backing material has a thickness of 1.0 mm, which brings about a good cushioning effect.
The backing material had an air permeability of 100 cm 3 /(cm 2 and a water vapour permeability of greater than 2500 g/(m 2 *24h) and could be torn both partly and right through by hand in both crosswise and lengthwise directions.
The hot-melt adhesive composition was applied to the backing by thermal screen printing.
The hot-melt adhesive composition was composed as follows: an A-B/A-B-A block copolymer, which consists of hard and soft segments, with a ratio of A-B-A to A-B of 2:1 and a styrene content in the polymer of 13 mol-%; its proportion in the adhesive composition is 40% by weight (Kraton G), a paraffinic hydrocarbon wax with a proportion in the adhesive composition of 51% by weight, hydrocarbon resins with a proportion of 7.5% by weight (Super Resin HC 140), an ageing inhibitor with a proportion of less than by weight (Irganox).
a hyperaemic active substance (nonanonyl vanillylamide); fraction--of 1%.
00 32 The components employed were homogenized in a thermal mixer at 125 0 C. The glass transition by the abovementioned method was -9°C.
Direct coating took place at 50 m/min and at a temperature of 120 0 C. The backing material was partially coated with 120 g/m 2 using a 14 mesh screen with a thickness of 300 pm.
The bandage produced by this method exhibited reversible detachment from the skin and good permeability for air and water vapour. No skin irritations were observed, and the epilation observed following the removal of the bandage was negligible.
Example 2 The backing material used was a viscose-based nonwoven.
The nonwoven was overstitched with a polyamide yarn, the yarn count being 7/cm sample width. The backing material was calendered and impregnated.
The backing material thus produced had an ultimate tensile stress strength of 12 N/cm and an ultimate tensile stress elongation of 28% in the lengthwise direction. The basis weight was 140 g/cm 2 Wetting the backing material completely was not possible owing to the choice of reinforcement materials. Without a load, the backing material has a thickness of 1.2 mm, which brings about a good cushioning effect.
The backing material had an air permeability of cm 3 /(cm 2 and a water vapour permeability of greater than 2500 g/(m 2 *24h) and could be torn both partly and right through by hand in both crosswise and lengthwise directions.
33 This hot-melt pressure-sensitive adhesive composition was composed as follows: an SEPS block copolymer, which consists of hard and soft segments, with a styrene content in the polymer of 13 mol-%; its proportion in the adhesive composition is 15% by weight (Kuraray Co.) a paraffinic hydrocarbon wax with a proportion in the adhesive composition of 44% by weight an ageing inhibitor with a proportion of less than by weight (Irganox 1010 Ciba) salicylic acid with a proportion of The components of the adhesive that were employed were homogenized in a thermal mixer at 185 0 C 3.5. The active substance was added in the cooling phase at 120 0 C and homogenization was continued in the mixer for 130 minutes.
The softening point of this adhesive composition was approximately 85 0 C (DIN 52011) and the adhesive composition showed a viscosity of 2100 mPas at 150 0
C
(DIN 53018, Brookfield DV II, Sp. 21). The glass transition by the abovementioned method was 10 0
C.
Using a nozzle, the self-adhesive composition was applied over the full area to the backing. Direct coating took place at 50 m/min and at a temperature of 120 0 C. The backing material was coated with 170 g/m 2 The plaster material produced in this way shows a comparatively good release of the active substance.

Claims (31)

1. Backing material for medical purposes, wherein the backing material is a nonwoven overstitched by means of yams and having an ultimate tensile stress strength of at least 10 N/cm and the backing material is coated partially or over its full area on at least one side with an adhesive composition comprising an active substance as herein described.
2. Backing material for medical purposes, wherein the backing material is a nonwoven which is reinforced by the formation of stitches formed by loops from the fibres of the web, the ultimate tensile stress strength of the backing material being at least 10 N/cm, and the backing material is coated partially or over its full area on at least one side with a self-adhesive composition comprising an active substance as herein described.
3. Backing material for medical purposes according to Claim 1 or Claim 2, wherein the number of stitches on the web is at least 3/cm.
4. Backing material according to Claim 3, wherein the stitches on the web are longitudinal stitches.
Backing material according to Claim 3 or Claim 4, wherein the number of stitches on the web is from 5 to
6. Backing material for medical purposes according to any one of Claims 1 to wherein the backing material generates a compression force of from 0.2 N/cm to 10 N/cm at an elongation of from 20% to
7. Backing material for medical purposes according to Claim 1 or Claim 2, wherein S"the backing material has a basis weight of up to 500 g/m 2
8. Backing material according to Claim 7, wherein the backing material has a basis weight from 10 to 350 g/m 2
9. Backing material for medical purposes according to Claim 1 or Claim 2, wherein the backing material is reinforced with one or more monofil, multifil, staple fibre Aor spun fibre yams and/or with oriented high-strength fibres, the yams and/or C fibres having in particular a strength of at least 40 cN/tex. 34a Backing material for medical purposes according to any one of the preceding claims, wherein the backing material can be torn by hand perpendicular to the orientation of the stitches and/or in the direction of the stitches and/or perpendicular to the orientation of the reinforcement and/or in the direction of the reinforcement.
C C C o CC
11. Backing material for medical purposes according to at least one of the preceding claims, wherein the adhesive composition comprises the releasable active substance or substances in an amount of from 0.01 to 60% by weight.
12. Backing material for medical purposes according to claim 11, wherein the adhesive composition comprises the releasable active substance or substances in an amount from 0.1 to 20% by weight.
13. Backing material for medical purposes according to at least one of the preceding claims, wherein the adhesive composition is a hot-melt adhesive composition.
14. Backing material for medical purposes according to at least one of the preceding claims, wherein the adhesive composition has a dynamic-complex glass transition 1 temperature at a frequency of 0.1 rad/s of less than
15. Backing material for medical purposes according to claim 14, wherein the adhesive composition has a dynamic-complex glass transition temperature at a frequency of 0.1 rad/s from 3°C to -30 0 C.
16. Backing material for medical purposes according to claim 15, wherein the adhesive composition has a dynamic-complex glass transition temperature at a frequency of ~0.1 rad/s from -3°C to -25 0 C.
17. Backing material for medical purposes according to at least one of the preceding claims, wherein the adhesive composition was foamed. 20
18. Backing material for medical purposes according to at least one of the preceding claims, wherein the adhesive composition is applied partially to the backing material, especially by halftone printing, thermal screen printing, thermal flexographic printing or intaglio printing.
19. Backing material for medical purposes according to at least one of the preceding claims, wherein the adhesive composition has been sprayed on.
Backing material for medical purposes according to at least one of the preceding claims, wherein the adhesive composition is applied in the form of polygeometric domes to the backing material.
21. Backing material for medical purposes according to at least one of the preceding claims, wherein the adhesive composition is applied to the backing material with a weight per unit area of greater than 15 g/m 2 477AUP00.Doc/LL -36-
22. Backing material for medical purposes according to claim 21, wherein the adhesive composition is applied to the backing material with a weight per unit area between g/m 2 and 500 g/m 2
23. Backing material for medical purposes according to claim 22, wherein the adhesive composition is applied to the backing material with a weight per unit area between 130 g/m 2 and 500 g/m 2
24. Backing material for medical purposes according to at least one of the preceding claims, wherein the adhesive composition can be sterilized.
Backing material for medical purposes according to claim 24, wherein the composition is sterilized with y (gamma) radiation.
26. Backing material for medical purposes according to one or more of the preceding claims, wherein the side opposite that coated with the self-adhesive composition, i the backing material is finished with a water-repellent layer, impregnation, release :-layer and/or coating.
27. Backing material for medical purposes according to one or more of the preceding claims, wherein at least one additional layer comprising sheets, foams or nonwovens is applied on the backing material.
28. Backing material for medical purposes according to one or more of the preceding claims, wherein the backing material is coated with metallic substances by vapour 20 deposition.
29. Backing material for medical purposes according to one or more of the preceding claims, wherein the coated backing material is covered after application of the self- adhesive composition or is provided with a wound pad or with padding.
A product comprising the backing material according to any one of claims 1 to 29.
31. Backing material for medical purposes according to any one of claims 1 to 29 and substantially as herein described with reference to any one of the examples but excluding comparative examples. DATED this 6th day of July 2001 BEIERSDORF AKTIENGESELLSCHAFT Attorney: CHARLES W. TANSEY Registered Patent and Trade Mark Attorney of Australia of BALDWIN SHELSTON WATERS 477aup.d S P 477aup0.do/SAP
AU25217/99A 1998-02-06 1999-02-04 Supporting material for medicinal purposes Ceased AU752378B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19804774 1998-02-06
DE19804774A DE19804774A1 (en) 1998-02-06 1998-02-06 Substrates for medical purposes
PCT/EP1999/000738 WO1999039756A2 (en) 1998-02-06 1999-02-04 Supporting material for medicinal purposes

Publications (2)

Publication Number Publication Date
AU2521799A AU2521799A (en) 1999-08-23
AU752378B2 true AU752378B2 (en) 2002-09-19

Family

ID=7856862

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25217/99A Ceased AU752378B2 (en) 1998-02-06 1999-02-04 Supporting material for medicinal purposes

Country Status (6)

Country Link
EP (1) EP1053030B1 (en)
AT (1) ATE226833T1 (en)
AU (1) AU752378B2 (en)
DE (2) DE19804774A1 (en)
ES (1) ES2185317T3 (en)
WO (1) WO1999039756A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19840191A1 (en) * 1998-09-03 2000-03-09 Lohmann Therapie Syst Lts Medicinal plaster with three functional layers
DE19921743A1 (en) * 1999-05-11 2000-11-16 Beiersdorf Ag Cohesive carrier material
DE10020102A1 (en) * 2000-04-22 2001-10-25 Beiersdorf Ag Procedure for partial application of high viscosity fluids to base material entails using nozzle with geometry such that at mouth of nozzle's fluid discharge gap a pressure increase takes place
DE10032537A1 (en) * 2000-07-05 2002-01-31 Labtec Gmbh Dermal system containing 2- (3-benzophenyl) propionic acid
ITTV20020008A1 (en) * 2002-01-25 2003-07-25 Al Pre Tec S R L Allergy Preve PROCEDURE FOR OBTAINING A SILK MANUFACTURE INDICATED IN THE TREATMENT OF CERTAIN SKIN AFFECTIONS OF THE HUMAN BODY
DE10207776A1 (en) * 2002-02-23 2003-09-04 Tesa Ag Process for the production of a partially coated plaster
DE10236319A1 (en) * 2002-08-08 2004-02-19 Beiersdorf Ag Active agent containing matrix plaster for the controlled delivery of an active agent to the skin comprises a pharmaceutical active agent containing a water insoluble adhesive matrix comprising a styrene block copolymer
DE10306187B4 (en) * 2003-02-13 2005-08-04 Steffen Barth plaster
DE102004058140B4 (en) * 2004-11-25 2007-09-20 Tesa Ag Hydroactive plaster with three-dimensional tangle coating
US20070179461A1 (en) * 2006-02-02 2007-08-02 Bristol-Myers Squibb Company Hot-melt silicone based ostomy and wound care skin attachment adhesives
DE102011081818A1 (en) * 2011-08-30 2013-02-28 Beiersdorf Ag Active skin coatings
US20210007899A1 (en) * 2018-04-02 2021-01-14 Marine Biology & Environmental Technologies, Llc Medical dressings and uses therof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4967740A (en) * 1986-06-11 1990-11-06 Minnesota Mining And Manufacturing Company Dispensable tapes
US5453319A (en) * 1992-05-18 1995-09-26 Minnesota Mining And Manufacturing Company Hot-melt-coatable adhesives
DE19531291A1 (en) * 1995-08-25 1997-02-27 Beiersdorf Ag Substrates for medical purposes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4224325C1 (en) * 1992-07-23 1994-02-10 Sanol Arznei Schwarz Gmbh Active ingredient plasters for low-melting and / or volatile active ingredients and process for its manufacture
DE4237252C2 (en) * 1992-11-04 1994-10-13 Zweckform Buero Prod Gmbh Flexible, removable, residue-free removable fabric, process for its production and its use
DE4442092C2 (en) * 1994-11-25 1996-12-05 Beiersdorf Ag Backside coated adhesive tape based on sewing fleece and its use
DE19631422A1 (en) * 1996-08-06 1998-02-12 Beiersdorf Ag Carrier materials equipped with self-adhesive

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4967740A (en) * 1986-06-11 1990-11-06 Minnesota Mining And Manufacturing Company Dispensable tapes
US5453319A (en) * 1992-05-18 1995-09-26 Minnesota Mining And Manufacturing Company Hot-melt-coatable adhesives
DE19531291A1 (en) * 1995-08-25 1997-02-27 Beiersdorf Ag Substrates for medical purposes

Also Published As

Publication number Publication date
ES2185317T3 (en) 2003-04-16
WO1999039756A3 (en) 1999-09-23
EP1053030A2 (en) 2000-11-22
ATE226833T1 (en) 2002-11-15
DE19804774A1 (en) 1999-08-12
AU2521799A (en) 1999-08-23
EP1053030B1 (en) 2002-10-30
DE59903247D1 (en) 2002-12-05
WO1999039756A2 (en) 1999-08-12

Similar Documents

Publication Publication Date Title
US6555730B1 (en) Supporting material for medical purposes
AU736935B2 (en) Active substance plasters
JP3847088B2 (en) Percutaneous absorption therapy system comprising a storage pressure sensitive adhesive layer and a unidirectional elastic backing layer
US7063859B1 (en) Barrier film lined backing layer composition and method for topical administration of active agents
AU752378B2 (en) Supporting material for medicinal purposes
US6459013B1 (en) Supporting material for medical purposes
US6544910B2 (en) Backing material for medical purposes
KR20060108511A (en) Adhesive preparation
US6656491B1 (en) Active substance plasters
US6488958B1 (en) Plasters containing active substances
WO2006018340A1 (en) Active agent-containing plaster strip for treating joint diseases
AU755609B2 (en) Device for releasing substances
AU731199B2 (en) Plasters for percutaneous absorption
AU762507B2 (en) Support material with a cohesive adhesive substance
AU770125B2 (en) Antislip coating on body-covering carrier materials, and use thereof
JP2001057991A (en) Air permeable pasting agent and its production

Legal Events

Date Code Title Description
SREP Specification republished
FGA Letters patent sealed or granted (standard patent)